LBO

A leveraged buyout is an acquisition where a financial sponsor funds most of the purchase price with borrowed money and a comparatively small equity contribution, and the acquired company's own future cash flows pay that debt down over a hold that typically runs five to seven years before the sponsor sells. Every interview walkthrough follows the same four-step arc. First, set the transaction assumptions: the purchase price (LTM EBITDA times an entry multiple), how much debt the deal can support, and the entry and exit multiple and growth assumptions that frame everything downstream. Second, build the sources and uses of funds, lining up debt from lenders and equity from the sponsor (plus any rolled-over equity from existing management) against the purchase price and fees, with the sponsor's equity check calculated last as the residual. Third, project the company's cash flows over the hold and build the debt schedule, since free cash flow pays interest and then retires principal each year. Fourth, work out the exit: apply an exit multiple (by default, the same one paid at entry) to the final year's EBITDA to get exit enterprise value, subtract whatever debt is left to get exit equity value, and divide that by the sponsor's original equity check for the return.

A private equity firm raises capital from outside investors (pension funds, endowments, insurance companies) and buys companies with it, aiming to sell them years later at a profit. The LBO is the standard structure for doing that, and funding most of the purchase with debt, rather than the sponsor's own capital, is what makes the return math work.

The mechanism is straightforward: putting in less equity for the same purchase means a given dollar of value created is divided across a smaller equity base, so it turns into a much larger percentage return, because the debt's claim is roughly fixed regardless of how well the business does and captures none of the appreciation. All of the value created inside a leveraged deal flows to the equity holder rather than being shared proportionally with the lender.

The same math runs in reverse. If the business is worth less at exit than the sponsor paid for it, the debt still has to be repaid in full first, so a modest decline in enterprise value can wipe out the equity entirely, a far worse outcome than the same decline would produce in an all-equity deal. Calling leverage a way to 'boost' returns misses this: it amplifies whatever the underlying deal produces, for better or worse, which is exactly why cash-flow stability is the first thing sponsors and lenders both look for before they will size a heavy debt load against a business.

Debt has three structural advantages over equity that make it the sponsor's preferred funding source, beyond the leverage effect itself. It is cheaper: lenders sit ahead of equity holders in the capital structure and get paid first if the deal goes bad, so they accept a lower return (senior debt in an LBO often prices around 6% to 8% pre-tax, against a 20%-plus IRR equity investors target), and interest is deductible against taxable income, so every dollar of interest expense shields roughly a quarter of a dollar of tax at a 25% rate, the after-tax cost of debt is the stated rate times one minus the tax rate. It frees up the sponsor's capital: a fund with a fixed pool of money can do four deals with $100 million of equity each instead of one deal with $400 million, so using more debt per deal, where the company's cash flow can support it, directly increases how many deals a given fund can do. And the debt sits on the acquired company, not on the sponsor: the PE firm sets up a holding company to make the purchase, the debt is secured against the target's own assets and cash flow, and if the deal fails badly enough to default, the sponsor loses its equity check but has no further personal liability for the debt.

Because the target has to service a heavy debt load from its own cash flow for five to seven years, LBO candidates look structurally different from the high-growth, cash-burning companies that attract venture or growth equity. Sponsors screen for steady, predictable cash flow (the single most important trait, since interest has to get paid whether or not a given month is strong), a mature industry with a defensible position and high barriers to entry, recurring revenue from subscriptions or long-term contracts (which is exactly what lenders price into how much debt they will extend), low capital spending (every dollar of capex is a dollar that cannot go toward debt repayment), a strong tangible asset base that gives lenders collateral, room to improve margins through cost discipline or better pricing, committed management willing to stay on (and ideally to roll over some of its own equity), and, above all, a purchase price that does not already assume the best case. A company with $25 million of stable, contracted EBITDA in a mature, unglamorous industry such as regional waste management is a textbook LBO candidate for exactly this reason: a pre-revenue biotech company with the same near-term burn is not, however attractive the underlying science, because its cash flow cannot support debt service and its value depends on binary outcomes no LBO underwriting can price. This is why LBO deal flow concentrates in software (recurring, high-margin, sticky customers), business services (multi-year contracts, fragmented markets suited to roll-ups), healthcare services (recession-resistant demand), and industrial or route-based services (contracted, repeatable revenue backed by hard assets).

The purchase enterprise value is what the sponsor agrees the operating business is worth, and it sets how much debt can be raised against it, how much equity the sponsor has to write a check for, and what the eventual exit needs to deliver. LTM EBITDA is the standard base for the entry multiple rather than next-twelve-months projections, for two reasons: lenders size the debt off the same LTM figure, so using a consistent base keeps the purchase price and the leverage on the same footing, and NTM numbers rely on management's own projections, which sellers running a competitive process tend to present toward the more aggressive end of what's plausible.

The entry multiple itself is sourced from three reference points, weighted in this order: trading comps (EV/EBITDA multiples of public peers, the most-cited reference since the data is current and the peer set is wide), precedent transactions (multiples actually paid in recent deals for similar businesses, useful because it reflects what a real acquirer paid rather than where the public market prices a minority stake), and a DCF, used only as a cross-check on whether the cash flows can plausibly support the price rather than as a primary input. A useful sanity check is comparing the entry multiple to the trading comps median: paying below that median improves the odds of an attractive exit multiple later, since the sponsor isn't already paying above where the market values similar businesses.

Most LBOs are structured on a cash-free, debt-free basis. The seller keeps whatever cash sits on the balance sheet at close and uses the sale proceeds to pay off all existing debt, handing the buyer a clean capital structure. Under this convention the buyer's check equals the purchase enterprise value, plus or minus a small working capital adjustment, since the seller is effectively funding both the departing cash and the retiring debt out of the proceeds it receives.

Typical entry multiples for middle-market LBOs run roughly 8x to 12x EBITDA, with the range driven by revenue quality, growth, margin profile, and capital intensity. Within that band, businesses with recurring, contracted revenue such as subscription software or healthcare services often clear 12x to 18x, while cyclical or capital-intensive businesses such as industrials or building products often trade at 6x to 9x, since a highly leveraged buyer is more exposed if EBITDA compresses in a downturn and free cash flow conversion is what actually pays down the debt.

Because the entry multiple is anchored to comps and precedent transactions, there is little room to argue over the multiple itself, so most of the real negotiation in an auction happens over what counts as EBITDA. Sellers typically present an adjusted LTM EBITDA that adds back items they call non-recurring: owner compensation above a market rate, one-off legal or restructuring costs, transaction expenses, and IT spend framed as a one-time investment rather than ongoing cost. Buyers push back by commissioning a quality-of-earnings report from an independent accounting firm, which tests each proposed add-back and produces a defensible adjusted EBITDA figure before any multiple gets applied to it.

Once the EBITDA base is settled, the multiple itself gets justified by checking it against three references at once: the trading comps median, recent precedent transactions in the sector, and what a DCF says the cash flows can support. A price that clears at least two of the three tends to survive investment-committee scrutiny, while one that sits above all three invites real pushback.

A DCF asks what a company is worth: it projects cash flows, discounts them at WACC, and produces an intrinsic value. An LBO valuation asks a different question entirely: what can a sponsor pay and still hit their required return, typically a 20% to 25% IRR over a multi-year hold. It starts from that required return, assumes an exit multiple, and back-solves for the maximum purchase price consistent with hitting it. Both are cash-flow-based methods, but they run in opposite directions and answer different questions, which is why they routinely produce different numbers on the same business.

This is also why the LBO valuation tends to sit at the low end of a football field of valuation methodologies. A financial sponsor is a return-constrained buyer: it has to clear its required IRR or the deal doesn't get done, which caps what it can pay. A strategic acquirer isn't constrained the same way, since it can extract synergies (cost takeouts, cross-sell revenue) that a standalone financial buyer cannot, and that extra earning power lets a strategic justify a higher price while still clearing its own return hurdle. The practical takeaway for a football field: precedent transactions tend to sit above the LBO floor because they capture those strategic premiums, with DCF and trading comps usually landing somewhere in between.

The Uses side gets built first, since the cost has to be known before the financing raised against it makes sense. Common Uses-side items, covering almost every typical buyout: purchase enterprise value (by far the largest line, equal to LTM EBITDA times the entry multiple); transaction fees, the advisory and legal fees paid to get the deal done, typically estimated around 2% of purchase enterprise value; financing fees, paid to lenders to arrange the debt (underwriting and commitment fees), typically 2% to 3% of total debt raised; and operating cash funded at close, a minimum cash balance so the company can run day to day without immediately drawing on its revolver.

The Sources side is filled in next, starting with debt (typically the largest component, sized as a multiple of LTM EBITDA based on what comparable deals have supported and what current credit markets and the company's cash flow can service), then any rollover equity from management or existing owners converting their pre-deal shares into the new entity rather than cashing out, and finally sponsor equity, the residual that makes the two sides balance.

Rollover equity is the value of pre-deal shares that management or existing owners agree to convert into shares of the post-LBO company instead of cashing out in full, typically in the 5% to 25% range of total post-deal equity. It reduces the cash the sponsor has to put up, since fewer new shares need to be purchased outright, and it's treated as a positive signal precisely because it means management is taking on the same future risk as the sponsor, aligning incentives over the hold period. Rollover holders end up owning the post-LBO company in proportion to their rollover relative to total equity, and that same proportion carries through to how exit proceeds get split.

Sponsor equity is calculated last, as whatever remains after debt and rollover are set: total uses minus total debt minus rollover equity minus any other sources. The sponsor's incentive throughout is to minimize this number, since a smaller equity check divided into the same dollar of exit proceeds produces a larger return.

Both fee types are cash payments due at close and both sit on the Uses side, but they're treated differently afterward, which is exactly why interviewers probe the distinction. Transaction fees, paid to bankers, lawyers, accountants, and consultants to close the deal, are expensed immediately and reduce retained earnings at close. Financing fees, paid to lenders to arrange the debt, are instead capitalized as a contra-debt asset and amortized over the life of the loan, so they show up on the post-close balance sheet and income statement in a different place and on a different schedule than transaction fees do, even though both were cash out the door on day one.

Total leverage in an LBO is quoted as total debt divided by EBITDA, and the level a deal can support varies by industry, credit-market conditions, and the stability of the business: a mature, highly predictable business-services company might support 5x to 6x or more, while a cyclical or capital-intensive business supports meaningfully less. For most US middle-market deals total leverage runs roughly 4x to 6x EBITDA, though the market-wide ceiling expands and contracts with credit conditions, looser markets and lower base rates support higher multiples, tighter conditions compress them. Lenders and rating agencies treat the leverage multiple as their primary risk gauge, so the real cap on how much debt a sponsor can raise for a given deal is what the lending market is willing to underwrite at that point in the cycle, not the sponsor's own preference. Lenders today also generally want the sponsor to fund at least around 25% of the purchase price with equity, which is why total debt in a modern deal usually runs 50% to 65% of the capital structure, well below the 80%-plus leverage common in 1980s-style LBOs.

LBO debt is split into tranches stacked by priority, and each layer's cost tracks its position: senior secured debt (a revolver and term loans, typically a Term Loan A held by banks with steady amortization and maintenance covenants, or a Term Loan B held by institutional investors with minimal amortization and lighter, covenant-lite terms) prices lowest, around 5% to 8%, because it's secured by the company's assets and repaid first; senior notes or unsecured/second-lien high-yield bonds sit next at roughly 7% to 9%; subordinated or mezzanine debt, often with an equity kicker and sometimes partly paid in kind, runs 9% to 18%; preferred equity sits below all debt but ahead of common equity, at 12% to 16%; and common equity (sponsor equity plus any management rollover), last in line and paid only after everyone else, targets 20%-plus. Banks generally cap what they will lend against the senior term loan at around 3x to 4x EBITDA, so a sponsor turns to bond and mezzanine investors, who take more risk for more yield, to fill the rest of the leverage target; blending the two raises more total debt at a lower overall cost than forcing one lender to fund the whole package.

The debt schedule tracks the balance owed on each tranche at the start of each year, how much gets paid down, and what's left at year end, turning the static capital structure at close into the debt paydown that actually builds equity value over the hold. Each year the company's free cash flow gets applied in a fixed order, the cash flow waterfall: interest on every tranche first, then any mandatory amortization the credit agreement requires (commonly a fixed percentage of the original term loan balance, often around 10% a year), then an optional cash sweep that uses whatever is left to prepay term loan principal early (sweep rates of 50% to 100% of remaining free cash flow are typical), with any leftover cash simply added to the balance sheet. Interest is usually charged on the balance outstanding at the start of the year, so as the term loan amortizes the interest bill shrinks and more cash becomes available for paydown the following year, while subordinated notes are almost always a bullet, repaid in one payment at maturity, so their balance sits untouched through the hold while the term loan absorbs the entire sweep. A revolver, a credit line the company draws on only when cash flow falls short of a required payment and repays once cash recovers, sits alongside this as a backstop; in a healthy deal it stays undrawn throughout, and a revolver that stays drawn for multiple years signals the capital structure was too aggressive for the underlying cash flow.

Some subordinated notes, mezzanine debt, and preferred stock charge PIK (payment-in-kind) interest, meaning the company doesn't pay it in cash each year but instead adds it to the loan balance, so the debt grows over time in exchange for the lender accepting deferred cash in return for a higher rate. PIK still counts as an expense on the income statement (lowering pre-tax income, taxes, and net income), gets added back as a non-cash item on the cash flow statement the same way D&A is, and raises the balance-sheet debt balance while retained earnings fall by the after-tax hit. It still has to be repaid in full at exit, so it adds directly to the net debt the sponsor pays off when the company sells, deferring cash cost during the hold without making the obligation disappear.

Separately, interest on any of this debt, cash or PIK, is tax-deductible, which is the tax shield: it lowers the company's cash tax bill, a real benefit but a smaller factor in overall returns than the entry and exit multiples or operating growth.

MOIC is the simplest return measure: total cash returned divided by total cash invested, so a 2.5x MOIC means every dollar of equity in came back as $2.50. It's intuitive and easy to communicate, but it ignores time entirely, a 3x MOIC over 3 years is a dramatically better annualized outcome than the same 3x MOIC over 10 years, even though the headline multiple is identical, and it ignores scale, since a 10x MOIC sounds spectacular until it turns out to be $1 turning into $10.

PE firms generally target a 2.0x to 3.0x MOIC over roughly a five-year hold, with 2.5x treated as a rough rule of thumb for a healthy deal. MOIC is most useful as a quick headline number and for comparing deals of similar length, but it should always be read alongside IRR, or at least a stated holding period, to mean much on its own.

IRR is the annualized rate that makes the net present value of every cash flow in the deal, the initial investment as an outflow, any interim distributions and the final exit as inflows, equal to zero: effectively the compounded annual growth rate of the equity. Unlike MOIC, it explicitly prices in the timing of cash flows, which is why it's the headline metric PE funds report to their limited partners and the one used to compare deals with different hold lengths.

Funds generally target something in the 15% to 25% range deal by deal, with 20% the long-standing market baseline, because limited partners (pension funds, endowments, sovereign wealth funds) allocate to private equity expecting a real premium over public equities (roughly 10% annualized for the S&P 500 over long periods) to compensate for illiquidity, multi-year lockups, and the 2%-management-fee-plus-20%-carry cost structure. IRR has real quirks: it's inflated by early interim distributions even when total dollars are unchanged, and it behaves oddly with irregular, sign-changing cash flow patterns, which is part of why sophisticated investors always look at IRR next to MOIC rather than trusting either alone.

MOIC answers 'how much money did this make, in total,' and IRR answers 'how efficiently, per year, did it make it,' and a deal can score well on one while looking mediocre on the other. A quick flip that returns 1.3x within a year is roughly a 30% IRR that most funds would not celebrate because the absolute dollars are small, while a 3.0x return over ten years is only about a 12% IRR that falls short of typical fund targets despite the healthy-looking multiple.

Three mental-math shortcuts convert between the two without a calculator: the Rule of 72 (years to double, about 72 divided by IRR, so a 12% IRR doubles money in about 6 years), the Rule of 114 (years to triple, about 114 divided by IRR), and the Rule of 144 (years to quadruple, about 144 divided by IRR), and all three invert cleanly to estimate IRR from a known multiple and hold period. Worth memorizing outright for a five-year hold: roughly 2.0x is about a 15% IRR, 2.5x about 20%, and 3.0x about 25%, with each extra half-turn of MOIC adding roughly 4 to 5 points of IRR; for a three-year hold, roughly 2.0x is about 26% and 3.0x is about 44%. For anything in between, the Rules of 72, 114, and 144 fill the gap.

A strategic sale exits the business to an operating company (often a competitor or adjacent player) that can pay a premium for synergies it can realize by combining the businesses, often the highest-price route when a strong strategic buyer exists. A sponsor-to-sponsor sale (a secondary buyout) exits to another private equity firm, common when a business still has a credible further growth story that a new sponsor, with a fresh investment thesis and hold period, is willing to pay for, but with no synergy premium the price typically lands below what a strategic would pay. An IPO exits by taking the company public, monetizing the position gradually (sponsors typically retain some ownership post-IPO, selling down over time rather than exiting all at once, which tends to lower the realized IRR even when the total multiple holds up), generally reserved for larger, well-established businesses with a strong enough growth story and scale to support public markets.

A fourth route, a dividend recapitalization, doesn't exit the position at all: the company raises new debt and pays the proceeds to the sponsor as a dividend, letting the fund pull some of its return forward while it keeps ownership. A recap is attractive when debt markets are open but the timing is wrong for a sale or IPO; it lifts IRR because cash comes back sooner, without changing how much the company is ultimately worth, and the trade-off is that the company carries more leverage again after having spent the hold delevering.

The original investment thesis usually has a specific exit route in mind from day one, since the type of value creation a sponsor pursues (operational improvement suited to a strategic buyer vs. continued growth suited to a secondary buyout) should logically point toward the exit that will pay the most for that specific kind of value.

The exit calculation moves top to bottom, in this order: exit enterprise value is final-year EBITDA times the exit multiple; exit equity value is exit enterprise value minus net debt at exit (debt remaining minus any cash on the balance sheet); MOIC is exit equity value divided by the sponsor's original equity invested; and IRR annualizes that MOIC over the years held. The most common error is skipping the net-debt subtraction and dividing exit enterprise value straight by the sponsor's equity, which overstates the return by the entire remaining debt balance, since enterprise value belongs to lenders and equity holders together and the debt has to come out before what's left goes to the sponsor. It's also a mistake to price the exit off entry-year EBITDA rather than the grown, final-year figure, since that would ignore everything the business earned across the hold.

Sponsors generally aim to exit once the primary value-creation levers (margin improvement, debt paydown, growth initiatives) have largely played out and the business is positioned to be attractive to the next buyer, exiting too early leaves value on the table; holding too long risks the fund's own timeline pressures (limited partnership agreements typically expect capital returned within a defined fund life) and risks market conditions turning against a sale.

Market timing also matters directly: exiting into a strong M&A or IPO market, when buyers are willing to pay up and financing is readily available, can meaningfully affect realized returns independent of how well the underlying business itself performed, which is why sponsors watch broader market conditions closely as a portfolio company approaches its planned exit window.

Exit value is driven by exit EBITDA (the scale the business has grown to) and exit multiple (what the market is willing to pay for that EBITDA at the time of sale), and the exit multiple itself is influenced by the buyer pool available (a wider pool of interested strategics and sponsors supports a higher price through competitive tension), the business's growth trajectory at the time of sale (a business still growing quickly commands a premium over one that has plateaued), and overall market conditions.

A sponsor preparing for exit typically works to position the business's growth story as favorably as possible in the run-up to a sale, since a buyer is paying largely for the business's expected future performance, not just its trailing results, which is why the final year or two of a hold period often focuses heavily on building a credible forward growth narrative for the eventual sale process.

A paper LBO is the interview version of a full leveraged buyout model: the interviewer reads out a handful of assumptions and expects a walkthrough by hand, with no spreadsheet and often no calculator, ending at an approximate MOIC and IRR in five to ten minutes. It is more common at elite boutiques than at bulge brackets, though it shows up at both, and it is tested just as much in the private-equity interviews that follow an IB analyst stint. The interviewer is reading the structure and the reasoning as much as the final number, which is why a clear, ordered walkthrough spoken out loud matters more than precision.

The five steps, in order: set every assumption (entry EBITDA, entry multiple, leverage, interest rate, growth rate, exit multiple, hold period) before touching any arithmetic; build sources and uses to size the purchase price and the debt, then solve for the sponsor's equity check as the plug; project the financial forecast, growing EBITDA (and, if asked, revenue and margin) across the hold; calculate free cash flow each year and net the cumulative total against the opening debt to find net debt at exit; and finally apply the exit multiple to exit-year EBITDA, subtract net debt for exit equity, and convert the result into MOIC and IRR.

Because there's no spreadsheet, a paper LBO leans on standard shortcuts: D&A and capex are often assumed to roughly offset each other so they can be dropped from the free-cash-flow build, working capital changes are usually ignored, and, unless told otherwise, all free cash flow is assumed to sweep straight to debt paydown rather than being split across a more realistic multi-tranche structure. None of these would survive in a real deal model, but they are expected here because the exercise is testing conceptual fluency under time pressure, not modeling precision, and stating each simplification out loud as you make it ('I'll assume D&A and capex net out') signals that you know it's a shortcut rather than a gap in your understanding.

How the page gets laid out also matters for speed: assumptions written down in a corner as the interviewer reads them out, so nothing has to be asked for twice; the projection built as a small table with years across the top and each line item down the side; a running cumulative free-cash-flow line kept directly under the free-cash-flow row, so net debt at exit is a single subtraction; and the bottom third of the page reserved for the returns math, sources and uses on one side and the exit calculation next to it, so the equity check and the exit equity sit next to each other when it's time to divide.

The fastest sanity check at the end is the MOIC-to-IRR table: for a five-year hold, roughly 2.0x lands near a 15% IRR, 2.5x near 20%, and 3.0x near 25%, with each additional half-turn of MOIC adding another 4 to 5 points. A result far outside that range for a normal, mid-single-digit-growth, moderate-leverage deal (a 10x MOIC, or barely above 1x) usually signals an arithmetic slip somewhere in the build, most often the mistake of dividing exit enterprise value by sponsor equity instead of subtracting net debt first. The Rule of 72 (years to double, about 72 divided by IRR), Rule of 114 (years to triple), and Rule of 144 (years to quadruple) all invert cleanly and cover most of the gaps between table rows.

Being able to catch your own implausible answer, out loud, is itself a positive signal, since it shows the same 'does this pass the smell test' instinct that matters in real modeling work, where a wrong sign or a misplaced decimal can otherwise go unnoticed until it's expensive.